357
Views
6
CrossRef citations to date
0
Altmetric
Review

Prospects for new and emerging therapeutics in severe asthma: the role of biologics

&
Pages 505-512 | Received 03 Feb 2017, Accepted 02 May 2017, Published online: 10 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Qiufen Xun, Jiulong Kuang, Qing Yang, Wei Wang & Guofeng Zhu. (2021) Glucocorticoid induced transcript 1 represses airway remodeling of asthmatic mouse via inhibiting IL-13/periostin/TGF-β1 signaling. International Immunopharmacology 97, pages 107637.
Crossref
Xue-peng Huang, Cheng-yu Qin & Yue-ming Gao. (2021) miR-135a inhibits airway inflammatory response in asthmatic mice via regulating JAK/STAT signaling pathway. Brazilian Journal of Medical and Biological Research 54:3.
Crossref
Svetlana P. Chapoval, Molly Hritzo, Xiulan Qi, Luca Tamagnone, Amit Golding & Achsah D. Keegan. (2019) Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1. ImmunoHorizons 3:2, pages 71-87.
Crossref
Wudan Yan. (2018) Toward Better Management for Asthma: From Smart Inhalers to Injections to Wearables, Researchers Are Finding New Ways to Improve Asthma Treatment. IEEE Pulse 9:1, pages 28-33.
Crossref
Marc Humbert, William Busse & Nicola A. Hanania. (2018) Controversies and opportunities in severe asthma. Current Opinion in Pulmonary Medicine 24:1, pages 83-93.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.